Insider filing
Traded Nov 13 · filed 1 day later
Routine share withholding; mechanical by default.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
EW · NYSE · Health Care Equipment
Edwards Lifesciences (EW) · oqro.io/stocks/EW · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$103.88−1.35 (−1.28%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Including 150 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Nov 13 · filed 1 day later
Routine share withholding; mechanical by default.
Daniel J. Lippis (Officer) plans to sell ~$194K of Edwards Lifesciences
Planned, from payDaniel J. Lippis (CVP, TAVR) sold ~$65K of Edwards Lifesciences
Planned saleTraded Nov 10, 2026 · largest single transaction ~$45K
Nov 10, 2026619 · @ $72.68
DetailsOfficial recordBernard J Zovighian (CEO) sold ~$1.43M of Edwards Lifesciences
Planned saleDonald E Jr Bobo (CVP,Strategy/Corp Development) sold ~$5.04M of Edwards Lifesciences
Planned saleDonald E. Bobo Jr (Officer) plans to sell ~$5.04M of Edwards Lifesciences
Planned, from payBernard J. Zovighian (Officer) plans to sell ~$4.76M of Edwards Lifesciences
Planned, from payBernard J Zovighian (CEO) sold ~$949K of Edwards Lifesciences
Planned saleTraded Nov 9, 2026 · largest single transaction ~$1.68M
Nov 9, 202623K
DetailsOfficial recordTraded Nov 9, 2026 · largest single transaction ~$3.55M
Nov 9, 202649K · @ $72.68
DetailsOfficial recordDaniel J. Lippis (CVP, TAVR) sold ~$53K of Edwards Lifesciences
Planned saleTraded Oct 8, 2026 · largest single transaction ~$45K
Oct 8, 2026619 · @ $72.68
DetailsOfficial recordTraded Sep 11 – Sep 14, 2026 · largest single transaction ~$48K
Sep 11, 2026355 · @ $86.77
DetailsOfficial recordInsider filing
Traded Sep 13 · filed 1 day later
Routine share withholding; mechanical by default.
Daniel J. Lippis (CVP, TAVR) sold ~$54K of Edwards Lifesciences
Planned saleTraded Sep 11, 2026 · largest single transaction ~$45K
Sep 11, 2026619 · @ $72.68
DetailsOfficial recordInsider filing
Traded Sep 11 · filed the same day
Routine share withholding; mechanical by default.
Insider selling
Traded Aug 31 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +14.5% · S&P 500 −6.7% · to Nov 19
Edwards Lifesciences's SVP, Corporate Controller sold $50K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Aug 28 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +15.2% · S&P 500 −7.0% · to Nov 19
Edwards Lifesciences's CVP, EMEACLA sold $238K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Traded Aug 26, 2026 · largest single transaction ~$2.79MNot reported under a pre-arranged trading plan
Aug 26, 2026~$2.79M · 31K sh @ $90.99
DetailsInsider selling
Traded Aug 26 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +14.4% · S&P 500 −6.5% · to Nov 19
Edwards Lifesciences's CVP, JAPAC sold $113K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Traded Aug 26, 2026 · largest single transaction ~$2.31M
Aug 26, 202632K
DetailsOfficial recordDaniel J. Lippis (CVP, TAVR) sold ~$57K of Edwards Lifesciences
Planned saleTraded Aug 11, 2026 · largest single transaction ~$45K
Aug 11, 2026619 · @ $72.68
DetailsOfficial recordTraded Jul 28 – Jul 30, 2026 · largest single transaction ~$819KNot reported under a pre-arranged trading plan
Jul 30, 2026~$13K · 146.31 sh @ $86.03
DetailsTraded Jul 28, 2026 · largest single transaction ~$713K
Jul 28, 20269,628
DetailsOfficial recordInsider selling
Traded Jul 27 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +25.1% · S&P 500 −3.1% · to Nov 19
The CEO of Edwards Lifesciences sold $245K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Jul 27 · filed the same day
Gift or transfer — classified separately from trades.
Nov 10, 2026619
Nov 9, 202649K
Aug 26, 2026~$106K · 1,154 sh @ $91.76
DetailsOfficial recordJul 28, 2026~$819K · 9,628 sh @ $85.06
DetailsOfficial record0 open-market purchases and 42 open-market sales by insiders of EW between Jan 11, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 4, 2026. The data provider lists the next release for Feb 8, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 4, 2026 | 1 sale | None | 4 sales |
| Jul 23, 2026 | 2 sales | None | 4 sales |
| Apr 23, 2026 | 5 sales | None | 10 sales |
| Feb 10, 2026 | None | None | 7 sales |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies